Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Aplastic (Phase 1/Phase 2)
Anemia, Diamond-Blackfan (Phase 1/Phase 2)
Anemia, Sickle Cell (Phase 1/Phase 2)
beta-Thalassemia (Phase 1/Phase 2)
Common Variable Immunodeficiency (Phase 1/Phase 2)
Deficiency Diseases (Phase 1/Phase 2)
Granuloma (Phase 1/Phase 2)
Hematologic Neoplasms (Phase 1/Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 1/Phase 2)
Job Syndrome (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Mycobacterium (Phase 1/Phase 2)
Neoplasms (Phase 1)
Neutropenia (Phase 1/Phase 2)
Pelvic Inflammatory Disease (Phase 1/Phase 2)
Primary Immunodeficiency Diseases (Phase 1/Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 1/Phase 2)
Scleroderma, Systemic (Phase 2)
Wiskott-Aldrich Syndrome (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue